Valeant, Ackman Lose In California Court, Must Face Insider Trading ChargesMark Melin
Just when Valeant Pharmaceuticals and Bill Ackman’s Pershing Square thought Andrew Left and Citron Research charges of impropriety were in the rear view mirror – Left announced yesterday he had lightened up on his short position in the stock – another shoe dropped in a California courtroom this week on an unrelated matter.
Valeant, Ackman and Pershing Square must face insider trading lawsuit, judge rules
U.S. District Judge . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.